Moza Al Hail

602 total citations
42 papers, 363 citations indexed

About

Moza Al Hail is a scholar working on Geriatrics and Gerontology, Public Health, Environmental and Occupational Health and Emergency Medical Services. According to data from OpenAlex, Moza Al Hail has authored 42 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Geriatrics and Gerontology, 14 papers in Public Health, Environmental and Occupational Health and 9 papers in Emergency Medical Services. Recurrent topics in Moza Al Hail's work include Pharmaceutical Practices and Patient Outcomes (16 papers), Patient Safety and Medication Errors (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Moza Al Hail is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (16 papers), Patient Safety and Medication Errors (7 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Moza Al Hail collaborates with scholars based in Qatar, United Kingdom and Ireland. Moza Al Hail's co-authors include Derek Stewart, Binny Thomas, Abdulrouf Pallivalapila, James S. McLay, Katie MacLure, Ahmed Awaisu, Lesley Diack, Vibhu Paudyal, Rajvir Singh and Zachariah Nazar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Moza Al Hail

37 papers receiving 351 citations

Peers

Moza Al Hail
Alejandra Salazar United States
Ghadah Asaad Assiri Saudi Arabia
Richard A. Hutchinson United States
Amy E. Lodolce United States
Michael A. Fotis United States
Alice L Bhasale Australia
Angela M. Wisniewski United States
Gillian Cavell United Kingdom
Moza Al Hail
Citations per year, relative to Moza Al Hail Moza Al Hail (= 1×) peers Abdulrouf Pallivalapila

Countries citing papers authored by Moza Al Hail

Since Specialization
Citations

This map shows the geographic impact of Moza Al Hail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moza Al Hail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moza Al Hail more than expected).

Fields of papers citing papers by Moza Al Hail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moza Al Hail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moza Al Hail. The network helps show where Moza Al Hail may publish in the future.

Co-authorship network of co-authors of Moza Al Hail

This figure shows the co-authorship network connecting the top 25 collaborators of Moza Al Hail. A scholar is included among the top collaborators of Moza Al Hail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moza Al Hail. Moza Al Hail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al‐Badriyeh, Daoud, et al.. (2025). Evaluating the economic impact of clinical pharmacist interventions in the women’s health setting in Qatar. International Journal of Clinical Pharmacy. 47(6). 1720–1729.
2.
Abushanab, Dina, Shereen Mohamed, Rania Abdellatif, et al.. (2025). Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis. Clinical Drug Investigation. 45(3). 151–163. 1 indexed citations
3.
Abushanab, Dina, Rania Abdellatif, Wadha Al‐Muftah, et al.. (2024). Cost-effectiveness analysis of genotype-guided optimization of major depression treatment in Qatar. Journal of Pharmaceutical Policy and Practice. 17(1). 2410197–2410197. 2 indexed citations
4.
Abushanab, Dina, et al.. (2024). A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unit. Journal of Pharmaceutical Policy and Practice. 17(1). 2345218–2345218. 1 indexed citations
5.
Al‐Badriyeh, Daoud, et al.. (2023). Characteristics of the clinical pharmacist interventions at the National Center for Cancer Care and Research Hospital in Qatar. Journal of Oncology Pharmacy Practice. 30(5). 792–801. 2 indexed citations
6.
Abushanab, Dina, et al.. (2023). Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar. PLoS ONE. 18(6). e0286419–e0286419. 10 indexed citations
7.
Hail, Moza Al, et al.. (2023). Behaviour and associated determinants of COVID-19 vaccine acceptance and advocacy: a nationwide survey of pharmacy professionals in Qatar. Journal of Pharmaceutical Policy and Practice. 16(1). 160–160.
8.
Nazar, Zachariah, Moza Al Hail, Abdulrouf Pallivalapila, et al.. (2023). Investigating physicians’ views on non-formulary prescribing: a qualitative study using the theoretical domains framework. International Journal of Clinical Pharmacy. 45(6). 1424–1433.
10.
11.
Stewart, Derek, Moza Al Hail, Abdulrouf Pallivalapila, et al.. (2022). A scoping review of theories used to investigate clinician adherence to clinical practice guidelines. International Journal of Clinical Pharmacy. 45(1). 52–63. 12 indexed citations
12.
Abushanab, Dina, Rania Abdellatif, Ayman El‐Menyar, et al.. (2022). TCTAP A-069 Cost-Effectiveness Analysis of High-Potency Versus Low-Potency Statins for Reducing Mortality in Coronary Artery Disease Patients on Dual Antiplatelet Therapy Post Percutaneous Coronary Intervention.. Journal of the American College of Cardiology. 79(15). S44–S44. 1 indexed citations
13.
Stewart, Derek, Abdulrouf Pallivalapila, Binny Thomas, et al.. (2021). A theoretically informed, mixed-methods study of pharmacists’ aspirations and readiness to implement pharmacist prescribing. International Journal of Clinical Pharmacy. 43(6). 1638–1650. 10 indexed citations
14.
Thomas, Binny, et al.. (2020). Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol. Systematic Reviews. 9(1). 161–161. 18 indexed citations
15.
Thomas, Binny, et al.. (2018). Knowledge and practice characteristics of pharmacists in Qatar towards medication use in pregnancy: a cross-sectional survey. Eastern Mediterranean Health Journal. 24(2). 137–145. 21 indexed citations
16.
Thomas, Binny, et al.. (2016). A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis. Clinical Pharmacology Advances and Applications. Volume 8. 199–202. 4 indexed citations
17.
Stewart, Derek, et al.. (2015). Building hospital pharmacy practice research capacity in Qatar: a cross-sectional survey of hospital pharmacists. International Journal of Clinical Pharmacy. 37(3). 511–521. 19 indexed citations
18.
Thomas, Binny, et al.. (2014). A case of probable labetalol induced hyperkalaemia in pre-eclampsia. International Journal of Clinical Pharmacy. 36(6). 1130–1133. 2 indexed citations
19.
Hail, Moza Al, et al.. (2012). 45. Incidence of Bacterial Isolates from Blood Culture in the Neonatal Intensive Care Unit of Tertiary Care Hospital. International Journal of Drug Development and Research. 4(4). 2 indexed citations
20.
Varghese, Robin, et al.. (2012). The Prevalence, Risk Factors, Maternal and Fetal outcomes inGestational Diabetes Mellitus. International Journal of Drug Development and Research. 4(3). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026